Hamilton, P, Kanigicherla, D, Hanumapura, P, Walz, L, Kramer, D, Fischer, M, Brenchley, P & Mitra, S 2017, ' Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM) : Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti-PLA2 R positive primary membranous nephropathy ', Journal of Clinical Apheresis . https://doi.org/10.1002/jca.21599